Preferred Label : aztreonam;

MeSH definition : A monocyclic beta-lactam antibiotic originally isolated from Chromobacterium violaceum. It is resistant to beta-lactamases and is used in gram-negative infections, especially of the meninges, bladder, and kidneys. It may cause a superinfection with gram-positive organisms.;

MeSH synonym : azthreonam; az-threonam; az threonam;

CISMeF synonym : esteve brand of aztreonam; aztreonam esteve brand; sanofi winthrop brand of aztreonam; squibb brand of aztreonam; aztreonam squibb brand; Bristol-Myers squibb brand of aztreonam; bristol myers squibb brand of aztreonam;

MeSH hyponym : SQ-26,776; urobactam; azactam; SQ 26,776; SQ26,776;

MeSH CAS label : propanoic acid, 2-(((1-(2-amino-4-thiazolyl)-2-((2-methyl-4-oxo-1-sulfo-3-azetidinyl)amino)-2-oxoethylidene)amino)oxy)-2-methyl-, (2S-(2alpha,3beta(Z)))-;

MeSH Related Number : 78110-38-0 (Aztreonam);

Registry Number MeSH : 78110-38-0;

MeSH annotation : do not use /biosyn unless by living matter;

Wikipedia link : https://en.wikipedia.org/wiki/Aztreonam;

Codes EINECS : 278-839-9;

Is substance : O;

UNII : G2B4VE5GH8;

InChIKey : WZPBZJONDBGPKJ-VEHQQRBSSA-N;

Details


Main resources

You can consult :

A monocyclic beta-lactam antibiotic originally isolated from Chromobacterium violaceum. It is resistant to beta-lactamases and is used in gram-negative infections, especially of the meninges, bladder, and kidneys. It may cause a superinfection with gram-positive organisms.

https://www.ema.europa.eu/en/medicines/human/EPAR/emblaveo
2024
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
drug combinations
avibactam
avibactam
aztreonam
aztreonam
anti-bacterial agents
anti-bacterial agents
adult
beta-Lactamase Inhibitors
beta-Lactamase Inhibitors
intraabdominal infections
complicated intra-abdominal infections
Healthcare-Associated Pneumonia
pyelonephritis
Gram-Negative aerobic bacteria
Gram-Negative bacterial infections
infusions, intravenous
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
aztreonam and beta-lactamase inhibitor

---
https://www.has-sante.fr/jcms/p_3534502/fr/emblaveo-aztreonam/avibactam-infections-graves
2024
false
false
false
France
drug combinations
anti-bacterial agents
treatment outcome
insurance, health, reimbursement
avibactam
Avibactam Sodium
beta-Lactamase Inhibitors
aztreonam
intraabdominal infections
complicated intra-abdominal infections
Complicated intra-abdominal infection
Healthcare-Associated Pneumonia
pneumonia, ventilator-associated
pyelonephritis
urinary tract infections
Gram-Negative bacterial infections
aztreonam and beta-lactamase inhibitor
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/jcms/c_1221610/cayston
http://www.has-sante.fr/portail/jcms/c_1701812/fr/cayston
http://www.has-sante.fr/portail/jcms/c_1701811/fr/cayston16102013avisct12973
2013
false
France
French
guidelines for drug use
antibiotic therapy
clinical trials, phase iii as topic
aztreonam
anti-bacterial agents
aztreonam
aztreonam
administration, inhalation
aztreonam
insurance, health, reimbursement
anti-bacterial agents
orphan drug production
adult
pseudomonas infections
pneumonia
pseudomonas aeruginosa
chronic disease
cystic fibrosis
treatment outcome
randomized controlled trials as topic
evaluation of the transparency committee
child
adolescent

---
https://www.ema.europa.eu/medicines/human/EPAR/Cayston
2012
United Kingdom
English
French
syndication feed
antibiotic therapy
orphan drug production
aztreonam
aztreonam
aztreonam
anti-bacterial agents
anti-bacterial agents
drug approval
drug labeling
treatment outcome
administration, inhalation
nebulizers and vaporizers
adult
chronic disease
cystic fibrosis
pneumonia
pregnancy
breast feeding
pseudomonas aeruginosa
pseudomonas infections
drug evaluation
summary of product characteristics
package leaflet

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=61054849
2012
France
summary of product characteristics
package leaflet
aztreonam
metered dose inhalers

---
http://www.has-sante.fr/portail/jcms/c_1245522/cayston-aztreonam-beta-lactamine-par-voie-inhalee
http://www.has-sante.fr/portail/jcms/c_1245518/cayston-15022012-synthese-ct8345
http://www.has-sante.fr/portail/jcms/c_1224124/cayston-15022012-avis-ct8345
2012
France
French
evaluation of the transparency committee
guidelines for drug use
antibiotic therapy
administration, inhalation
adult
cystic fibrosis
aztreonam
aztreonam
anti-bacterial agents
anti-bacterial agents
treatment outcome
pseudomonas aeruginosa
pseudomonas infections
pneumonia
aztreonam
insurance, health, reimbursement
chronic disease
clinical trials, phase iii as topic
comparative study

---
http://www.has-sante.fr/portail/jcms/c_1062729/azactam
http://www.has-sante.fr/portail/upload/docs/application/pdf/2011-06/azactam_-_ct-_10553.pdf
2011
France
French
evaluation of the transparency committee
antibiotic therapy
aztreonam
anti-bacterial agents
insurance, health, reimbursement
aztreonam
injections, intravenous
injections, intramuscular
infusions, intravenous
adult

---
http://www.infectiologie.com/UserFiles/File/medias/Recos/2011-Argu-Reco-CaSFM.pdf
2011
false
true
true
false
false
France
French
guidelines for drug use
microbial sensitivity tests
cephalosporins
aztreonam
enterobacteriaceae
Extended-spectrum beta lactamase (substance)
aztreonam
cephalosporins

---
Summary Basis of Decision (SBD) CAYSTON
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailOne.php?lang=fr&linkID=SBD00027
2010
false
Canada
French
English
antibiotic therapy
pseudomonas infections
aztreonam
administration, inhalation
anti-bacterial agents
aztreonam
pneumonia
pseudomonas aeruginosa
cystic fibrosis
treatment outcome
drug approval
monograph pharmacy
drug information

---
http://www.lecrat.eu/?s=Aztr%C3%A9onam
2009
France
French
antibiotic therapy
pregnancy
aztreonam
anti-bacterial agents
aztreonam
drug information

---
http://www.meddispar.fr/medicaments/3692085
2008
France
French
drug prescriptions
injections
aztreonam
legislation, drug
aztreonam
drug information

---
http://www.has-sante.fr/portail/display.jsp?id=c_601807
http://www.has-sante.fr/portail/display.jsp?id=c_601806
2007
France
French
antibiotic therapy
aztreonam
anti-bacterial agents
adult
cystic fibrosis
drug resistance, multiple, bacterial
urinary tract infections
drug interactions
pregnancy
aztreonam
anti-bacterial agents
injections, intramuscular
injections, intravenous
renal insufficiency
infusions, intravenous
continuity of patient care
aztreonam
anti-bacterial agents
pseudomonas infections
respiratory tract infections
pseudomonas aeruginosa
cross infection
drug prescriptions
aztreonam
guidelines for drug use

---
Nous contacter.
26/04/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.